Archives
- 2026-08
- 2026-07
- 2026-06
- 2026-05
- 2026-04
- 2026-03
- 2026-02
- 2026-01
- 2025-12
- 2025-11
- 2025-10
- 2025-09
- 2025-03
- 2025-02
- 2025-01
- 2024-12
- 2024-11
- 2024-10
- 2024-09
- 2024-08
- 2024-07
- 2024-06
- 2024-05
- 2024-04
- 2024-03
- 2024-02
- 2024-01
- 2023-12
- 2023-11
- 2023-10
- 2023-09
- 2023-08
- 2023-07
- 2023-06
- 2023-05
- 2023-04
- 2023-03
- 2023-02
- 2023-01
- 2022-12
- 2022-11
- 2022-10
- 2022-09
- 2022-08
- 2022-07
- 2022-06
- 2022-05
- 2022-04
- 2022-03
- 2022-02
- 2022-01
- 2021-12
- 2021-11
- 2021-10
- 2021-09
- 2021-08
- 2021-07
- 2021-06
- 2021-05
- 2021-04
- 2021-03
- 2021-02
- 2021-01
- 2020-12
- 2020-11
- 2020-10
- 2020-09
- 2020-08
- 2020-07
- 2020-06
- 2020-05
- 2020-04
- 2020-03
- 2020-02
- 2020-01
- 2019-12
- 2019-11
- 2019-10
- 2019-09
- 2019-08
- 2019-07
- 2019-06
- 2019-05
- 2019-04
- 2018-11
- 2018-10
- 2018-07
-
PEG-Lipids Govern LNP mRNA Delivery Performance
2026-08-17
Borah and colleagues show that PEG-lipid identity can strongly influence LNP transfection even when PEG-lipid represents a minor formulation component. Across HeLa cells and mouse intramuscular, subcutaneous, and intravenous studies, DMG-PEG 2000 outperformed DSG-PEG 2000 with several ionisable lipids, highlighting PEG-tail selection as a practical determinant of mRNA delivery performance.
-
ARCA Cy5 EGFP mRNA (5-moUTP) Workflow Guide
2026-08-17
Track mRNA uptake and EGFP translation in the same mammalian-cell experiment with a directly labeled reporter. This workflow guide shows how to benchmark delivery systems, distinguish internalization from productive expression, and troubleshoot common formulation and imaging failures.
-
Diminazene Aceturate: Research Workflows
2026-08-16
Diminazene Aceturate supports two distinct research directions: trypanosome parasite experiments and mechanistic ACE2 activation studies. This practical guide connects formulation, assay design, mitochondrial readouts, and troubleshooting without confusing an antiparasitic research tool with a clinical treatment.
-
Aprotinin (BPTI) Research Workflows
2026-08-15
Aprotinin combines reversible serine protease control with practical value in fibrinolysis, inflammation, and blood-cell research. This guide translates its biochemical profile into reproducible workflows, including a cautious bridge to red blood cell membrane mechanics.
-
Targeted mRNA Nanoparticles in Ischemic Stroke
2026-08-14
Gao and colleagues developed mannose receptor-targeted lipid nanoparticles that deliver interleukin-10 mRNA to microglia in ischemic brain tissue. In mouse stroke models, this feedback-driven strategy promoted protective microglial polarization, reduced neuroinflammation, restored blood–brain barrier integrity, and improved neurological outcomes.
-
Cy5-UTP RNA Labeling: Workflows and Troubleshooting
2026-08-14
Cy5-UTP enables direct, fluorescence-based RNA probe synthesis without a post-labeling reaction, supporting FISH, multiplex analysis, and dual-color expression arrays. This practical guide connects reaction design, storage control, assay selection, and troubleshooting to reliable readouts.
-
FITC Goat Anti-Mouse IgG (H+L) Antibody Guide
2026-08-13
The FITC Goat Anti-Mouse IgG (H+L) Antibody provides fluorescent detection and secondary-antibody signal amplification when mouse IgG primary antibodies are used in immunofluorescence, microscopy, or flow cytometry. It should not be selected for non-mouse immunoglobulins, non-fluorescent detection systems, or live-cell workflows unless compatibility with its sodium azide-containing formulation has been established.
-
BMS 599626 Dihydrochloride: Assay Design
2026-08-13
BMS 599626 dihydrochloride offers a precise way to dissect EGFR/HER2 signaling while separating pathway inhibition from senescence-associated effects. This article translates its kinase selectivity and machine-learning senolytic research into a state-aware experimental framework.
-
LY364947: TGF-β Type I Receptor Kinase Inhibitor
2026-08-12
LY364947 provides a reversible, pathway-proximal way to test how TGF-β signaling drives Smad2 activation, EMT, fibrosis-related phenotypes, and retinal injury responses. This guide translates the compound into a practical workflow and connects it to the CDK4/6–BET findings reported in pancreatic cancer research.
-
IR-1061 Near Infrared Fluorescent Dye Workflow
2026-08-12
IR-1061 is a near infrared fluorescent dye designed for OTN-NIR deep-tissue imaging, where reduced background can improve visualization in complex biological samples. This workflow connects fresh DMSO preparation with polarity-matched nanoparticle loading, physiological stability testing, and practical troubleshooting for reproducible optical imaging.
-
Dual Luciferase Reporter Gene System for BMSCs
2026-08-11
Learn how a Dual Luciferase Reporter Gene System can convert lncRNA–pathway hypotheses into quantitative regulatory evidence in BMSCs. This article connects the MRF–FSHR–cAMP–PKA–CREB findings of a 2025 study with practical reporter design, normalization, controls, and interpretation.
-
Dual Luciferase Reporter Gene System for Causal Mapping
2026-08-11
Learn how the Dual Luciferase Reporter Gene System can convert complex transcriptional networks into quantitative, internally normalized measurements. Using the MYC2–LBD40/42–CRL3BPM4 module as a design case, this article presents a causal framework for reporter selection, controls, and assay interpretation.
-
GM 6001 for ECM and MMP Research
2026-08-10
GM 6001, also called Galardin, provides a nanomolar tool for testing how MMP-driven extracellular matrix remodeling affects tissue repair, signaling, cancer phenotypes, and neural perineuronal nets. This guide combines practical dosing, controls, troubleshooting, and a reference-study-informed workflow for separating matrix protection from downstream pathway effects.
-
H-Aggregated IR-1061 for NIR-II Cancer Therapy
2026-08-09
Yu et al. developed RRIALP-C4, an RR9-functionalized anionic liposome that carries IR-1061 and carboplatin while transferring the fluorophore’s H-aggregated state to tumor cell membranes. The resulting formulation combines NIR-II fluorescence imaging, photothermal therapy, and temperature-sensitive chemotherapy release, providing a mechanistically informed strategy for image-guided cancer treatment.
-
Cy5 amine (non-sulfonated): Labeling Guide
2026-08-08
Cy5 amine (non-sulfonated) is a primary-amine cyanine reagent for covalent labeling of suitably activated proteins, peptides, polymers, and other biomolecules. It is water-insoluble, so it should be dissolved in an organic co-solvent before aqueous coupling and should not be used for direct aqueous labeling or diagnostic applications.